GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types
GOPC:ROS1 和其他 ROS1 融合基因是多种胶质瘤类型中罕见但反复出现的药物靶点。
期刊:Acta Neuropathologica
影响因子:9.3
doi:10.1007/s00401-021-02369-1
Sievers, Philipp; Stichel, Damian; Sill, Martin; Schrimpf, Daniel; Sturm, Dominik; Selt, Florian; Ecker, Jonas; Kazdal, Daniel; Miele, Evelina; Kranendonk, Mariëtte E G; Tops, Bastiaan B J; Kohlhof-Meinecke, Patricia; Beschorner, Rudi; Kramm, Christof M; Hasselblatt, Martin; Reifenberger, Guido; Capper, David; Wesseling, Pieter; Stenzinger, Albrecht; Milde, Till; Korshunov, Andrey; Witt, Olaf; Pfister, Stefan M; Wick, Wolfgang; von Deimling, Andreas; Jones, David T W; Sahm, Felix